Another great point. In mid 2020 in a conference call, Gary said PCTL was having logistical problems getting their product into the UK. In addition, they have continued this messaging.
Moving forward, the UK health system has finally "opened logistically" and is now getting product into their hospitals.
Each country PCTL supplies (and new ones added) will have its own opportunities and challenges due to bureaucratic policies.
Changing gears... The nature of COVID itself as a novel infection and the world's reaction will be studied for a long time. And its still an ongoing event with, for example, mutations.
Looking backwards as an investor for this product: Using this strategy as a primary method to gauge the future of this company makes little-to-no sense considering the above.